info icon

Congenital viral diseases

P16_CONGN_VIRAL_DISEA

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 P35
  • Cause of death: ICD-10 P35

2 out of 7 registries used, show all original rules.

13

4. Check minimum number of events

None

13

5. Include endpoints

None

13

6. Filter based on genotype QC (FinnGen only)

13

Control definitions (FinnGen only)

Control exclude
P16_INFECTIONS_SPECIFIC_PERINA_PERIOD

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
P3
Name in latin
Morbi virales congeniti

Case counts by codes

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 421 203 217
Only index persons 222 107 115
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.00 0.00 0.00
Median age at first event (years)
Whole population 0.23 0.21 0.06
Only index persons 0.11 0.14 0.09

-FinnGen-

Key figures

All Female Male
Number of individuals 13 9 -
Unadjusted period prevalence (%) 0.00 0.00 -
Median age at first event (years) 14.57 0.12 -

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40758558) Short blood count panel - Blood
6
20
4.64
1.84
4.5
2.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
0
31
0.00
1.15
0.0
1.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
7
40
2.61
0.92
5.6
6.2
mmol/l
5.4
5.7
—
7
35
(3017143) Hepatitis C virus Ab [Presence] in Serum
5
26
2.48
0.81
1.8
1.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
5
33
1.83
0.48
4.0
3.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
5
33
1.83
0.48
3.0
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
5
34
1.76
0.47
11.6
4.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
41
1.85
0.45
2.2
2.9
—
—
—
0
0
(3044889) 12 lead EKG panel
6
44
1.67
0.42
1.7
3.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
8
59
1.92
0.42
6.0
4.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
7
54
1.64
0.40
11.7
6.0
e9/l
2.9
4.1
—
7
44
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
37
1.57
0.28
1.8
2.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
5
39
1.45
0.27
2.6
2.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
6
46
1.56
0.26
5.2
4.7
—
0.0
—
0
13
(3035350) Ketones [Presence] in Urine by Test strip
6
48
1.46
0.25
3.2
3.7
—
0.0
—
0
14
(3006315) Basophils [#/volume] in Blood
6
49
1.41
0.25
12.8
4.5
e9/l
0.0
0.0
—
6
41
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
5
62
0.69
0.24
5.6
2.3
mmol/l
2.5
2.8
—
5
57
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
5
62
0.69
0.24
5.0
2.2
mmol/l
1.4
1.5
—
5
57
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
11
0.00
0.22
0.0
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
0
13
0.00
0.22
0.0
3.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
6
50
1.37
0.12
12.8
4.4
e9/l
0.5
0.5
—
6
42
(3013115) Eosinophils [#/volume] in Blood
6
52
1.28
0.11
13.0
4.3
e9/l
0.2
0.2
—
6
43
(3013707) Erythrocyte sedimentation rate by Westergren method
7
61
1.32
0.11
7.3
3.7
mm/h
8.7
8.0
—
7
53
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
6
0.00
0.00
0.0
5.8
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
8.8
—
1.0
—
0
6
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
0
6
0.00
0.00
0.0
2.5
—
5.2
—
0
6
(3001122) Ferritin [Mass/volume] in Serum or Plasma
5
51
0.97
0.00
2.6
2.2
ug/l
33.4
34.8
—
5
45
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
0
6
0.00
0.00
0.0
1.3
—
0.0
—
0
6
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
1.4
—
0
6
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
0.2
—
0
6
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
3.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
0
7
0.00
0.00
0.0
1.6
—
3.9
—
0
7
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
5
0.00
0.00
0.0
1.8
—
44.7
—
0
5
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
0
5
0.00
0.00
0.0
12.2
—
97.8
—
0
5
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
5
47
1.10
0.00
3.8
3.8
—
0.0
—
0
13

Mortality – FinRegistry

Association

Association between endpoint P16_CONGN_VIRAL_DISEA and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have P16_CONGN_VIRAL_DISEA.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: P16_CONGN_VIRAL_DISEA – Congenital viral diseases

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data